1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Heart Failure, Preserved Ejection Fraction: new trials by email Literature Review of Heart Failure, Preserved Ejection Fraction trials Research Report on Heart Failure, Preserved Ejection Fraction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction SGLT2 inhibitor - Heart Failure, Preserved Ejection Fraction | Phase 4 | Unknown | Samsung Medical Center | 154 | 2024-05-01 | 2024-04-08 |
Cardiovascular Diseases (1) · Heart Diseases (1) · Heart Failure (1)
Sodium-Glucose Transporter 2 Inhibitors (1)
South Korea (1)